Autologous bone marrow stem cell therapy for patients undergoing coronary artery bypass grafting: A meta-analysis of 14 randomized controlled trials

Autologous bone marrow stem cell (BMSC) therapy is a novel option for regenerative therapy in patients with ischemic heart disease. The aim of the present meta-analysis was to evaluate the effectiveness of BMSCs combined with coronary artery bypass grafting (CABG). The PubMed, Cochrane Library, EMBA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shanlian, Yao, Liang, Yan, Peijing, Bao, Qiangwei, Dong, Xin, Liu, Xingguang, Zhu, Yan, Su, Xin, Wang, Aqian, Duan, Yichao, Yang, Kehu, Zhang, Min, Cao, Yunshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425237/
https://www.ncbi.nlm.nih.gov/pubmed/30906476
http://dx.doi.org/10.3892/etm.2019.7283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425237/
https://www.ncbi.nlm.nih.gov/pubmed/30906476
http://dx.doi.org/10.3892/etm.2019.7283

Ejemplares similares